Abstract
The actual therapeutic strategies opposing the cardiovascular disease (CVD) are not able to completely arrest the progression of the atherosclerotic process. Over recent years, mesenchymal stem cell (MSC) transplantation has been emerging as a safe, and promising approach to treat CVD. Of note, different types of stem cells are available, and, among them, embryonic stem cells, MSCs, induced pluripotent stem cells, endothelial progenitor cells, and adipose-derived regenerative cells are under current investigation. In the present perspective, major emphasis will be placed on MSCs for their capacity to restore heart, and artery activities.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Endocrine, metabolic & immune disorders drug targets
Paper Title
Journal
Date
